The relative binding affinities of PDZ partners for CFTR: a biochemical basis for efficient endocytic recycling.

The cystic fibrosis transmembrane conductance regulator (CFTR) is an epithelial chloride channel mutated in patients with cystic fibrosis. Its expression and functional interactions in the apical membrane are regulated by several PDZ (PSD-95, discs large, zonula occludens-1) proteins, which mediate protein-protein interactions, typically by binding C-terminal recognition motifs. In particular, the CFTR-associated ligand (CAL) limits cell-surface levels of the most common disease-associated mutant DeltaF508-CFTR. CAL also mediates degradation of wild-type CFTR, targeting it to lysosomes following endocytosis. Nevertheless, wild-type CFTR survives numerous cycles of uptake and recycling. In doing so, how does it repeatedly avoid CAL-mediated degradation? One mechanism may involve competition between CAL and other PDZ proteins including Na (+)/H (+) exchanger-3 regulatory factors 1 and 2 (NHERF1 and NHERF2), which functionally stabilize cell-surface CFTR. Thus, to understand the biochemical basis of WT-CFTR persistence, we need to know the relative affinities of these partners. However, no quantitative binding data are available for CAL or the individual NHERF2 PDZ domains, and published estimates for the NHERF1 PDZ domains conflict. Here we demonstrate that the affinity of the CAL PDZ domain for the CFTR C-terminus is much weaker than those of NHERF1 and NHERF2 domains, enabling wild-type CFTR to avoid premature entrapment in the lysosomal pathway. At the same time, CAL's affinity is evidently sufficient to capture and degrade more rapidly cycling mutants, such as DeltaF508-CFTR. The relatively weak affinity of the CAL:CFTR interaction may provide a pharmacological window for stabilizing rescued DeltaF508-CFTR in patients with cystic fibrosis.

[1]  B. Papsin,et al.  Misfolding diverts CFTR from recycling to degradation , 2004, The Journal of cell biology.

[2]  A. Piserchio,et al.  The PDZ1 Domain of SAP90 , 2002, The Journal of Biological Chemistry.

[3]  J. Riordan,et al.  The PDZ-binding Chloride Channel ClC-3B Localizes to the Golgi and Associates with Cystic Fibrosis Transmembrane Conductance Regulator-interacting PDZ Proteins* , 2003, The Journal of Biological Chemistry.

[4]  P. Schatz,et al.  Peptide binding consensus of the NHE‐RF‐PDZ1 domain matches the C‐terminal sequence of cystic fibrosis transmembrane conductance regulator (CFTR) , 1998, FEBS letters.

[5]  Sudhir C. Sharma,et al.  Design, synthesis, and evaluation of linear and cyclic peptide ligands for PDZ10 of the multi-PDZ domain protein MUPP1. , 2007, Biochemistry.

[6]  S Grinstein,et al.  The delta F508 mutation decreases the stability of cystic fibrosis transmembrane conductance regulator in the plasma membrane. Determination of functional half-lives on transfected cells. , 1993, The Journal of biological chemistry.

[7]  N. Heintz,et al.  A Novel Protein Complex Linking the δ2 Glutamate Receptor and Autophagy Implications for Neurodegeneration in Lurcher Mice , 2002, Neuron.

[8]  G. Cutting,et al.  PDZ Domain Interaction Controls the Endocytic Recycling of the Cystic Fibrosis Transmembrane Conductance Regulator* , 2002, The Journal of Biological Chemistry.

[9]  A. Bretscher,et al.  An Apical PDZ Protein Anchors the Cystic Fibrosis Transmembrane Conductance Regulator to the Cytoskeleton* , 1998, The Journal of Biological Chemistry.

[10]  W. Stafford,et al.  Analysis of heterologous interacting systems by sedimentation velocity: curve fitting algorithms for estimation of sedimentation coefficients, equilibrium and kinetic constants. , 2004, Biophysical chemistry.

[11]  T. Leung,et al.  Structural Basis of the Na+/H+ Exchanger Regulatory Factor PDZ1 Interaction with the Carboxyl-terminal Region of the Cystic Fibrosis Transmembrane Conductance Regulator* , 2001, The Journal of Biological Chemistry.

[12]  Min Goo Lee,et al.  Dynamic Regulation of Cystic Fibrosis Transmembrane Conductance Regulator by Competitive Interactions of Molecular Adaptors* , 2007, Journal of Biological Chemistry.

[13]  A. Beaudet,et al.  Interactions with PDZ Domain Proteins PIST/GOPC and PDZK1 Regulate Intracellular Sorting of the Somatostatin Receptor Subtype 5* , 2005, Journal of Biological Chemistry.

[14]  Gavin MacBeath,et al.  Uncovering quantitative protein interaction networks for mouse PDZ domains using protein microarrays. , 2006, Journal of the American Chemical Society.

[15]  T. Flotte,et al.  The Short Apical Membrane Half-life of Rescued ΔF508-Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Results from Accelerated Endocytosis of ΔF508-CFTR in Polarized Human Airway Epithelial Cells* , 2005, Journal of Biological Chemistry.

[16]  Prisca Boisguerin,et al.  An improved method for the synthesis of cellulose membrane-bound peptides with free C termini is useful for PDZ domain binding studies. , 2004, Chemistry & biology.

[17]  L. Cantley,et al.  Recognition of Unique Carboxyl-Terminal Motifs by Distinct PDZ Domains , 1997, Science.

[18]  Jiunn R Chen,et al.  PDZ Domain Binding Selectivity Is Optimized Across the Mouse Proteome , 2007, Science.

[19]  V. Rybin,et al.  Computer-aided design of a PDZ domain to recognize new target sequences , 2002, Nature Structural Biology.

[20]  Prisca Boisguerin,et al.  Characterization of a Putative Phosphorylation Switch: Adaptation of SPOT Synthesis to Analyze PDZ Domain Regulation Mechanisms , 2007, Chembiochem : a European journal of chemical biology.

[21]  Aleksandr Kivenson,et al.  Targeting CAL as a negative regulator of DeltaF508-CFTR cell-surface expression: an RNA interference and structure-based mutagenetic approach. , 2007, The Journal of biological chemistry.

[22]  R. Boucher Airway surface dehydration in cystic fibrosis: pathogenesis and therapy. , 2007, Annual review of medicine.

[23]  A. Bretscher,et al.  A kinase-regulated PDZ-domain interaction controls endocytic sorting of the β2-adrenergic receptor , 1999, Nature.

[24]  D. Xie,et al.  Molecular basis of cooperativity in protein folding. V. Thermodynamic and structural conditions for the stabilization of compact denatured states , 1994, Proteins.

[25]  Seth G. N. Grant,et al.  PDZ Domain Proteins: Plug and Play! , 2003, Science's STKE.

[26]  G. Cutting,et al.  A PDZ-binding motif is essential but not sufficient to localize the C terminus of CFTR to the apical membrane. , 2001, Journal of cell science.

[27]  P. Schuck,et al.  Calculating sedimentation coefficient distributions by direct modeling of sedimentation velocity concentration profiles. , 2004, Methods in enzymology.

[28]  J M Sturtevant,et al.  Thermodynamics of the binding of L-arabinose and of D-galactose to the L-arabinose-binding protein of Escherichia coli. , 1983, The Journal of biological chemistry.

[29]  M. Welsh,et al.  A C-terminal motif found in the beta2-adrenergic receptor, P2Y1 receptor and cystic fibrosis transmembrane conductance regulator determines binding to the Na+/H+ exchanger regulatory factor family of PDZ proteins. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[30]  J. Marshall,et al.  Defective intracellular transport and processing of CFTR is the molecular basis of most cystic fibrosis , 1990, Cell.

[31]  Nicole Caspers,et al.  A thermodynamic ligand binding study of the third PDZ domain (PDZ3) from the mammalian neuronal protein PSD-95. , 2007, Biochemistry.

[32]  R. Marchase,et al.  Rapid endocytosis of the cystic fibrosis transmembrane conductance regulator chloride channel. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[33]  J. Ladbury,et al.  Isothermal titration calorimetry of biomolecules , 1998 .

[34]  Matthew P. Anderson,et al.  Processing of mutant cystic fibrosis transmembrane conductance regulator is temperature-sensitive , 1992, Nature.

[35]  G. Cutting,et al.  A Golgi-associated PDZ Domain Protein Modulates Cystic Fibrosis Transmembrane Regulator Plasma Membrane Expression* , 2002, The Journal of Biological Chemistry.

[36]  Andrea Piserchio,et al.  Targeting specific PDZ domains of PSD-95; structural basis for enhanced affinity and enzymatic stability of a cyclic peptide. , 2004, Chemistry & biology.

[37]  M. Conese,et al.  Na+/H+ Exchanger Regulatory Factor Isoform 1 Overexpression Modulates Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Expression and Activity in Human Airway 16HBE14o- Cells and Rescues ΔF508 CFTR Functional Expression in Cystic Fibrosis Cells* , 2005, Journal of Biological Chemistry.

[38]  P. Schuck,et al.  Reliable determination of binding affinity and kinetics using surface plasmon resonance biosensors. , 1997, Current opinion in biotechnology.

[39]  J. Schlessinger,et al.  Measurement of the binding of tyrosyl phosphopeptides to SH2 domains: a reappraisal. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[40]  J. Larusch,et al.  PDZ‐binding motifs are unable to ensure correct polarized protein distribution in the absence of additional localization signals , 2005, FEBS letters.

[41]  D. Mak,et al.  Regulation of cystic fibrosis transmembrane conductance regulator single-channel gating by bivalent PDZ-domain-mediated interaction. , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[42]  N. Bradbury,et al.  E3KARP Mediates the Association of Ezrin and Protein Kinase A with the Cystic Fibrosis Transmembrane Conductance Regulator in Airway Cells* , 2000, The Journal of Biological Chemistry.

[43]  J. Hell,et al.  Selectivity and Promiscuity of the First and Second PDZ Domains of PSD-95 and Synapse-associated Protein 102* , 2002, The Journal of Biological Chemistry.

[44]  Jian-guo Li,et al.  Ezrin-Radixin-Moesin-binding Phosphoprotein-50/Na+/H+ Exchanger Regulatory Factor (EBP50/NHERF) Blocks U50,488H-induced Down-regulation of the Human κ Opioid Receptor by Enhancing Its Recycling Rate* , 2002, The Journal of Biological Chemistry.

[45]  Z. X. Wang,et al.  An exact mathematical expression for describing competitive binding of two different ligands to a protein molecule , 1995, FEBS letters.

[46]  Andrea Piserchio,et al.  Association of the cystic fibrosis transmembrane regulator with CAL: structural features and molecular dynamics. , 2005, Biochemistry.

[47]  F. Collins,et al.  Chloride conductance expressed by delta F508 and other mutant CFTRs in Xenopus oocytes. , 1991, Science.

[48]  G. Roomans Pharmacological Approaches to Correcting the Ion Transport Defect in Cystic Fibrosis , 2003, American journal of respiratory medicine : drugs, devices, and other interventions.

[49]  Junqi He,et al.  Interaction with Cystic Fibrosis Transmembrane Conductance Regulator-associated Ligand (CAL) Inhibits β1-Adrenergic Receptor Surface Expression* , 2004, Journal of Biological Chemistry.

[50]  Pascal Barbry,et al.  Altered chloride ion channel kinetics associated with the ΔF508 cystic fibrosis mutation , 1991, Nature.

[51]  G. Joberty,et al.  PIST: a novel PDZ/coiled-coil domain binding partner for the rho-family GTPase TC10. , 2001, Biochemical and biophysical research communications.

[52]  W. Guggino,et al.  Modulation of Mature Cystic Fibrosis Transmembrane Regulator Protein by the PDZ Domain Protein CAL* , 2004, Journal of Biological Chemistry.

[53]  A. Naren,et al.  Macromolecular complexes of cystic fibrosis transmembrane conductance regulator and its interacting partners. , 2005, Pharmacology & therapeutics.

[54]  D. Callaway,et al.  Ezrin Controls the Macromolecular Complexes Formed between an Adapter Protein Na+/H+ Exchanger Regulatory Factor and the Cystic Fibrosis Transmembrane Conductance Regulator* , 2005, Journal of Biological Chemistry.